Prøve GULL - Gratis

INDIA'S CANCER - PREVENTION BLUEPRINT

Healthcare Radius

|

February 2024

India faces a formidable foe: cancer With cases projected to rise by 57.5 percent by 2040, understanding the landscape of this disease is crucial. Leading oncologists offer valuable insights into the most prevalent cancers and their regional variations.

INDIA'S CANCER - PREVENTION BLUEPRINT

Head and neck cancers, particularly oral cancers, stand tall as the most common, according to Dr Vijay Agarwal, Lead Consultant, Medical oncology, Apollo Hospitals, Bengaluru and Dr Jyoti Mehta, Consultant Radiation and Clinical Oncologist, TGH Oncolife Cancer Center, Talegao. This grim reality is attributed to widespread tobacco use, especially in the states of eastern and western India, as Dr Satish Rao, Surgical Oncologist, Lilavati Hospital, and Dr Nikhil Dharmadhikari MBBS MS (General Surgery) DrNB (Surgical Oncology) Fellowship in Advanced Laparoscopic Surgery (Oncology) Laparoscopic and Robotic Surgeon, Holy Family Hospital, Bandra, Mumbai specify. Dr Naveen Hedne Chandrsekhar, Senior Consultant, Head and Neck - Surgical Oncology, Apollo Proton Cancer Center, Chennai paints a stark picture, calling India the capital of oral cancer' due to smokeless tobacco's grip.

Beyond tobacco, regional factors come into play. Dr Sreenivasa BJ, Medical Oncologist and Breast Health Specialist, HCG Cancer Hospital, Bengaluru describes the influence of lifestyle, genetics, and environment on cancer distribution. Dr Vijay Agarwal of Apollo Hospitals and TGH Oncolife's Dr Jyoti Mehta point to breast and ovarian cancers dominating the southern parts of India, while the northern states are facing the challenge of esophageal and stomach cancers.

FLERE HISTORIER FRA Healthcare Radius

Healthcare Radius

Healthcare Radius

VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM

Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.

time to read

1 mins

December 2025

Healthcare Radius

Healthcare Radius

A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026

The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.

time to read

12 mins

December 2025

Healthcare Radius

Healthcare Radius

FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA

From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.

time to read

6 mins

December 2025

Healthcare Radius

ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US

Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS

Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL

Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH

Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.

time to read

1 min

December 2025

Healthcare Radius

Healthcare Radius

OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS

By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”

time to read

7 mins

December 2025

Healthcare Radius

Healthcare Radius

MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM

Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.

time to read

1 min

December 2025

Listen

Translate

Share

-
+

Change font size